Sparstolonin B suppresses lipopolysaccharide-induced inflammation in human umbilical vein endothelial cells.
about
Sparstolonin B, a novel plant derived compound, arrests cell cycle and induces apoptosis in N-myc amplified and N-myc nonamplified neuroblastoma cellsA Novel Urotensin II Receptor Antagonist, KR-36996 Inhibits Smooth Muscle Proliferation through ERK/ROS Pathway.Sparstolonin B attenuates hypoxia-induced apoptosis, necrosis and inflammation in cultured rat left ventricular tissue slicesDetermination of sparstolonin B by ultra-high performance liquid chromatography coupled with triple quadrupole mass spectrometry: application to pharmacokinetic study of sparstolonin B in rat plasma.Sparstolonin B suppresses rat vascular smooth muscle cell proliferation, migration, inflammatory response and lipid accumulation.Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activationBlockade of Urotensin II Receptor Prevents Vascular Dysfunction.Sparstolonin B attenuates hypoxia-reoxygenation-induced cardiomyocyte inflammation.Chemical constituents from the tubers of Scirpus yagara and their anti-inflammatory activities.Effects of Citral on Lipopolysaccharide-Induced Inflammation in Human Umbilical Vein Endothelial Cells.Identifying Chinese Herbal Medicine Network for Endometriosis: Implications from a Population-Based Database in TaiwanChrysin Attenuates VCAM-1 Expression and Monocyte Adhesion in Lipopolysaccharide-Stimulated Brain Endothelial Cells by Preventing NF-κB Signaling.Sodium tanshinone IIA sulfonate prevents lipopolysaccharide-induced inflammation via suppressing nuclear factor-κB signaling pathway in human umbilical vein endothelial cells.TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis.The in vitro effect of lipopolysaccharide on proliferation, inflammatory factors and antioxidant enzyme activity in bovine mammary epithelial cells.
P2860
Q28538332-F9944B76-4B1A-4C97-AF09-49BEFC8B65C0Q33655911-4C9A75C9-2783-463C-91E8-6135818F8A18Q34183935-30E3C85E-F8A4-4556-A061-F5AB8F61A877Q35570182-B0F7BAD0-B3CC-41BF-9AEA-090E889DE2B3Q35613249-8DD41300-57D6-4F24-8519-F37ABEA30D03Q36775835-9E5B5F19-99AF-4CCC-BB6E-F929F2E7AA06Q37235264-1FE7118D-F718-4139-B16E-92F61EA0D0F8Q39029151-2938F164-B683-48D2-B493-7C1996CB92E0Q39934849-10A7D1EE-30BC-408F-BCF6-49617B53BBB3Q40874383-D01AED1A-3651-4AD3-B991-1D3B8829FDF8Q40979616-23127F91-1B14-478B-B05E-5E03AD46C530Q41181941-CC3969C5-434D-44EA-B2E3-DB18BC87EBC9Q47990226-0971F3D5-4C63-4403-B8A8-64DF6B0F1C65Q48641496-35AB7176-01C6-41FA-B77F-DC53A62F3578Q55283852-E8406ABB-13E9-4E06-9980-16A13AC3C7C0
P2860
Sparstolonin B suppresses lipopolysaccharide-induced inflammation in human umbilical vein endothelial cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Sparstolonin B suppresses lipo ...... ilical vein endothelial cells.
@ast
Sparstolonin B suppresses lipo ...... ilical vein endothelial cells.
@en
Sparstolonin B suppresses lipo ...... ilical vein endothelial cells.
@nl
type
label
Sparstolonin B suppresses lipo ...... ilical vein endothelial cells.
@ast
Sparstolonin B suppresses lipo ...... ilical vein endothelial cells.
@en
Sparstolonin B suppresses lipo ...... ilical vein endothelial cells.
@nl
prefLabel
Sparstolonin B suppresses lipo ...... ilical vein endothelial cells.
@ast
Sparstolonin B suppresses lipo ...... ilical vein endothelial cells.
@en
Sparstolonin B suppresses lipo ...... ilical vein endothelial cells.
@nl
P2093
P2860
P921
P1476
Sparstolonin B suppresses lipo ...... bilical vein endothelial cells
@en
P2093
Daping Fan
Jin'ao Duan
Qiaoli Liang
Xiaodong Cui
P2860
P2888
P304
P356
10.1007/S12272-013-0120-8
P577
2013-04-20T00:00:00Z
P6179
1014002669